ASX - By Stock
|
PYC |
Re:
Ann: PMS Drug Candidate Effective In Human Brain Cells
|
|
fyffee
|
29 |
6.6K |
1 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
29
|
6.6K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
Ann: PMS Drug Candidate Effective In Human Brain Cells
|
|
fyffee
|
29 |
6.6K |
10 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
29
|
6.6K
|
10
|
|
ASX - By Stock
|
PYC |
Re:
Ann: PMS Drug Candidate Effective In Human Brain Cells
|
|
fyffee
|
29 |
6.6K |
8 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
29
|
6.6K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
fyffee
|
10K |
4.8M |
11 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
10K
|
4.8M
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
fyffee
|
10K |
4.8M |
20 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
10K
|
4.8M
|
20
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Phase 2 trial shows significant improvements in Pitt Hopkins
|
|
fyffee
|
160 |
80K |
1 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
160
|
80K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Phase 2 trial shows significant improvements in Pitt Hopkins
|
|
fyffee
|
160 |
80K |
25 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
160
|
80K
|
25
|
|
ASX - By Stock
|
PYC |
Re:
FDA orphan designation
|
|
fyffee
|
14 |
6.7K |
4 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
14
|
6.7K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trading Halt
|
|
fyffee
|
231 |
120K |
1 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
231
|
120K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
fyffee
|
285 |
129K |
1 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
285
|
129K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
fyffee
|
285 |
129K |
2 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
285
|
129K
|
2
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
fyffee
|
285 |
129K |
8 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
285
|
129K
|
8
|
|
ASX - By Stock
|
PYC |
Re:
Ann: $74.6 Million Extension of Cash Runway
|
|
fyffee
|
15 |
5.2K |
1 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
15
|
5.2K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Ann: DAYBUE net sales US$87.1 million in Q4 2023
|
|
fyffee
|
79 |
38K |
8 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
79
|
38K
|
8
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
fyffee
|
1.7K |
891K |
7 |
26/02/24 |
26/02/24 |
Charts
|
1.7K
|
891K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
fyffee
|
605 |
272K |
0 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
605
|
272K
|
0
|
|
ASX - By Stock
|
STX |
Re:
Ann: Bell Potter Unearthed Presentation
|
|
fyffee
|
114 |
50K |
2 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
114
|
50K
|
2
|
|
ASX - By Stock
|
STX |
Re:
Ann: SE3 confirms continuity at South Erregulla
|
|
fyffee
|
307 |
108K |
0 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
307
|
108K
|
0
|
|
ASX - By Stock
|
STX |
Re:
Support for domgas review
|
|
fyffee
|
344 |
134K |
20 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
344
|
134K
|
20
|
|
ASX - By Stock
|
STX |
Re:
Support for domgas review
|
|
fyffee
|
344 |
134K |
7 |
11/02/24 |
11/02/24 |
ASX - By Stock
|
344
|
134K
|
7
|
|
ASX - By Stock
|
STX |
Re:
Support for domgas review
|
|
fyffee
|
344 |
134K |
12 |
11/02/24 |
11/02/24 |
ASX - By Stock
|
344
|
134K
|
12
|
|
ASX - By Stock
|
NTI |
Re:
Are we better than Neuron ?
|
|
fyffee
|
6 |
2.5K |
2 |
10/02/24 |
10/02/24 |
ASX - By Stock
|
6
|
2.5K
|
2
|
|
ASX - By Stock
|
STX |
Re:
Support for domgas review
|
|
fyffee
|
344 |
134K |
0 |
10/02/24 |
10/02/24 |
ASX - By Stock
|
344
|
134K
|
0
|
|
ASX - By Stock
|
STX |
Re:
Support for domgas review
|
|
fyffee
|
344 |
134K |
14 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
344
|
134K
|
14
|
|
ASX - By Stock
|
STX |
Re:
Ann: Trading Halt
|
|
fyffee
|
300 |
133K |
3 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
300
|
133K
|
3
|
|
ASX - By Stock
|
STX |
Re:
Ann: Trading Halt
|
|
fyffee
|
300 |
133K |
13 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
300
|
133K
|
13
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
fyffee
|
1.7K |
891K |
0 |
06/02/24 |
06/02/24 |
Charts
|
1.7K
|
891K
|
0
|
|
ASX - By Stock
|
STX |
Re:
Ann: Walyering Production Update
|
|
fyffee
|
186 |
79K |
21 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
186
|
79K
|
21
|
|
ASX - By Stock
|
STX |
Re:
Ann: Walyering Production Update
|
|
fyffee
|
186 |
79K |
0 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
186
|
79K
|
0
|
|
ASX - By Stock
|
STX |
Re:
STX Charts
|
|
fyffee
|
1.5K |
632K |
1 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
1.5K
|
632K
|
1
|
|
ASX - By Stock
|
STX |
Re:
Ann: 2Q FY24 Quarterly Report & Appendix 5B
|
|
fyffee
|
347 |
121K |
4 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
347
|
121K
|
4
|
|
ASX - By Stock
|
STX |
Re:
Ann: 2Q FY24 Quarterly Report & Appendix 5B
|
|
fyffee
|
347 |
121K |
2 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
347
|
121K
|
2
|
|
ASX - By Stock
|
STX |
Re:
STX Charts
|
|
fyffee
|
1.5K |
632K |
0 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
1.5K
|
632K
|
0
|
|
ASX - By Stock
|
STX |
Re:
STX Charts
|
|
fyffee
|
1.5K |
632K |
10 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
1.5K
|
632K
|
10
|
|
ASX - By Stock
|
STX |
Re:
STX Charts
|
|
fyffee
|
1.5K |
632K |
3 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
1.5K
|
632K
|
3
|
|
ASX - By Stock
|
STX |
Re:
STX Charts
|
|
fyffee
|
1.5K |
632K |
2 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
1.5K
|
632K
|
2
|
|
ASX - By Stock
|
STX |
Re:
STX Charts
|
|
fyffee
|
1.5K |
632K |
2 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
1.5K
|
632K
|
2
|
|
ASX - By Stock
|
STX |
Re:
STX Charts
|
|
fyffee
|
1.5K |
632K |
13 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
1.5K
|
632K
|
13
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
fyffee
|
1.7K |
891K |
1 |
22/01/24 |
22/01/24 |
Charts
|
1.7K
|
891K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
fyffee
|
1.0K |
537K |
1 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
1.0K
|
537K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
fyffee
|
1.0K |
537K |
10 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
1.0K
|
537K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
fyffee
|
1.0K |
537K |
16 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
1.0K
|
537K
|
16
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
fyffee
|
1.0K |
537K |
4 |
21/01/24 |
21/01/24 |
ASX - By Stock
|
1.0K
|
537K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
fyffee
|
1.0K |
537K |
9 |
21/01/24 |
21/01/24 |
ASX - By Stock
|
1.0K
|
537K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
fyffee
|
1.0K |
537K |
10 |
21/01/24 |
21/01/24 |
ASX - By Stock
|
1.0K
|
537K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
fyffee
|
1.0K |
537K |
16 |
21/01/24 |
21/01/24 |
ASX - By Stock
|
1.0K
|
537K
|
16
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
fyffee
|
1.0K |
537K |
0 |
21/01/24 |
21/01/24 |
ASX - By Stock
|
1.0K
|
537K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
fyffee
|
1.0K |
537K |
2 |
21/01/24 |
21/01/24 |
ASX - By Stock
|
1.0K
|
537K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
fyffee
|
1.0K |
537K |
1 |
20/01/24 |
20/01/24 |
ASX - By Stock
|
1.0K
|
537K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
fyffee
|
1.0K |
537K |
5 |
20/01/24 |
20/01/24 |
ASX - By Stock
|
1.0K
|
537K
|
5
|
|